Literature DB >> 21375789

Chlamydia trachomatis Infection in minority adolescent women: a public health challenge.

Christie M J L Cooksey1, Erica K Berggren, Jennifer Lee.   

Abstract

UNLABELLED: Chlamydia trachomatis is the most common bacterial sexually transmitted infection in the United States. This disease disproportionately affects adolescent minority women, and untreated infection can lead to lasting reproductive tract morbidity. Recommendations for primary prevention include patient counseling to decrease risky behavior and increase barrier protection use; secondary prevention recommendations include screening and treatment of affected individuals and their sexual partners, barrier contraception use, as well as counseling to decrease behaviors that lead to reinfection. Despite these strategies, both incidence and prevalence of Chlamydia have continued to escalate in this population. Interventions to decrease chlamydial infection should encompass all facets of primary and secondary prevention as well as address the fundamental barrier to prevention-lack of perception of risk in this young age group. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING
OBJECTIVES: After completion of this educational activity, the obstetrician/gynecologist should be better able to identify current screening guidelines to test for chlamydial infection in sexually active adolescents; obtain more thorough sexual histories, and understand dynamics of disproportionate disease burden in minority teens; recognize and act to decrease the high risk of reinfection in this patient population; and employ novel methods to increase STI screening. 2010 Lippincott Williams & Wilkins, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21375789      PMCID: PMC3723806          DOI: 10.1097/OGX.0b013e3182110204

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  40 in total

1.  Chlamydia screening in a Health Plan before and after a national performance measure introduction.

Authors:  Gale R Burstein; Mark H Snyder; Deborah Conley; Daniel R Newman; Cathleen M Walsh; Guoyu Tao; Kathleen L Irwin
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

Review 2.  A review of female-condom effectiveness: patterns of use and impact on protected sex acts and STI incidence.

Authors:  Gowri Vijayakumar; Zonke Mabude; Jenni Smit; Mags Beksinska; Mark Lurie
Journal:  Int J STD AIDS       Date:  2006-10       Impact factor: 1.359

3.  Reliability of partner reports of sexual history in a heterosexual population at a sexually transmitted diseases clinic.

Authors:  N J Ellish; C S Weisman; D Celentano; J M Zenilman
Journal:  Sex Transm Dis       Date:  1996 Nov-Dec       Impact factor: 2.830

4.  A sensitive method for evaluating condoms as virus barriers.

Authors:  C D Lytle; J E Duff; B Fleharty; R L Bidinger; W H Cyr; L B Routson
Journal:  J AOAC Int       Date:  1997 Mar-Apr       Impact factor: 1.913

5.  An in vitro evaluation of condoms as barriers to a small virus.

Authors:  C D Lytle; L B Routson; G B Seaborn; L G Dixon; H F Bushar; W H Cyr
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

6.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

7.  Perceived risk of chlamydial and gonococcal infection among sexually experienced young adults in the United States.

Authors:  Carol A Ford; James Jaccard; Susan G Millstein; Philip E Bardsley; William C Miller
Journal:  Perspect Sex Reprod Health       Date:  2004 Nov-Dec

Review 8.  Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies.

Authors:  Lee Warner; Katherine M Stone; Maurizio Macaluso; James W Buehler; Harland D Austin
Journal:  Sex Transm Dis       Date:  2006-01       Impact factor: 2.830

9.  High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors.

Authors:  R E Bunnell; L Dahlberg; R Rolfs; R Ransom; K Gershman; C Farshy; W J Newhall; S Schmid; K Stone; M St Louis
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

10.  Understanding changes in sexual activity among young metropolitan men: 1979-1995.

Authors:  L Ku; F L Sonenstein; L D Lindberg; C H Bradner; S Boggess; J H Pleck
Journal:  Fam Plann Perspect       Date:  1998 Nov-Dec
View more
  4 in total

1.  Electronic Health Record Reminders for Chlamydia Screening in an American Indian Population.

Authors:  Michael Sang Hughes; Andria Apostolou; Brigg Reilley; Jessica Leston; Jeffrey McCollum; Jonathan Iralu
Journal:  Public Health Rep       Date:  2020-12-10       Impact factor: 2.792

2.  Amoebal endosymbiont Parachlamydia acanthamoebae Bn9 can grow in immortal human epithelial HEp-2 cells at low temperature; an in vitro model system to study chlamydial evolution.

Authors:  Chikayo Yamane; Tomohiro Yamazaki; Shinji Nakamura; Junji Matsuo; Kasumi Ishida; Sumire Yamazaki; Satoshi Oguri; Natsumi Shouji; Yasuhiro Hayashi; Mitsutaka Yoshida; Hiroyuki Yamaguchi
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

3.  Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia

Authors:  Nataly Orozco-Hoyos; Armando Baena; Carolina Montoya-Ruiz; Gloria I Sánchez; Eliana Restrepo
Journal:  Biomedica       Date:  2020-09-01       Impact factor: 0.935

4.  Nanoparticle-Based Lateral Flow Biosensor Integrated With Loop-Mediated Isothermal Amplification for Rapid and Visual Identification of Chlamydia trachomatis for Point-of-Care Use.

Authors:  Xu Chen; Qingxue Zhou; Yan Tan; Ronghua Wang; Xueli Wu; Jiangli Liu; Rui Liu; Shuoshi Wang; Shilei Dong
Journal:  Front Microbiol       Date:  2022-07-12       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.